In the first case, David Lally, MD presents a patient case of age-related macular degeneration (AMD) highlighting the superior durability of newer treatments.

Now Viewing

EP: 1.Case 1: Treatment-Naïve Neovascular Age-Related Macular Degeneration

EP: 2.First Line Treatment Decisions for Age-Related Macular Degeneration

EP: 3.Case 2: Diabetic Macular Edema With Severe Vision Loss

EP: 4.MOA and Improved Outcomes: Gaps in Measuring Real-World Results

EP: 5.Case 3: Persistently Active Central Retinal Vein Occlusion

EP: 6.Safety of Advanced Therapies in Clinical Trials vs Real World Experience

EP: 7.Case 4: Neovascular Age-Related Macular Degeneration with Serious Pigment Epithelial Detachment

EP: 8.Final Thoughts on Case Presentations and Advanced Therapies

Related Content

December 4th 2024

Foundation Fighting Blindness joins University of Colorado Anschutz Medical Campus and leading institutions receive funding to fast track whole eye transplantation program

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

September 26th 2024

Las complejidades en la adopción de una nueva tecnología

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

May 13th 2024

Study: CRISPR gene editing leads to improvements in vision for people with inherited blindness

May 13th 2024

Researchers: ‘Smart’ contact lenses may one day enable wireless glaucoma detection

Do Not Sell My Personal Information

Job Board

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777